Super Glivec on the phase II study in Korea.

Published: 2005-09-16 06:57:00
Updated: 2005-09-16 06:57:00
Super Glivec, a second generation of the targeted anti-cancer drug to overcome any resistance, seems to put on the phase II study in Korea.

Prof. Kim Dong-wook, Euijeong-bu St. Mary hospital, the internal hematolgy medicine department, said that he would conduct the phase II study for AMN-107,...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.